Abstract:Osteogenesis imperfecta (OI) is a heritable and chronically debilitating skeletal dysplasia. Patients with OI typically present with reduced bone mass, tendency for recurrent fractures, short stature and bowing deformities of the long bones. Mutations causative of OI have been identified in over 20 genes involved in collagen folding, posttranslational modification and processing, and in bone mineralization and osteoblast development. In 2016, we described the first X-linked recessive form of OI caused by MBTPS2 missense variants in patients with moderate to severe phenotypes. MBTPS2 encodes site-2 protease, a Golgi transmembrane protein that activates membrane-tethered transcription factors. These transcription factors regulate genes involved in lipid metabolism, bone and cartilage development, and ER stress response. The interpretation of genetic variants in MBTPS2 is complicated by the gene's pleiotropic properties; MBTPS2 variants can also cause the dermatological conditions Ichthyosis Follicularis, Atrichia and Photophobia (IFAP), Keratosis Follicularis Spinulosa Decalvans (KFSD) and Olmsted syndrome (OS) without skeletal abnormalities typical of OI. Using control and patient-derived fibroblasts, we previously identified gene expression signatures that distinguish MBTPS2 -OI from MBTPS2 -IFAP/KFSD and observed stronger suppression of genes involved in fatty acid metabolism in MBTPS2 -OI than in MBTPS2 -IFAP/KFSD; this was coupled with alterations in the relative abundance of fatty acids in MBTPS2 -OI. Furthermore, we observed a reduction in collagen deposition in the extracellular matrix by MBTPS2 -OI fibroblasts. Here, we extrapolate our observations in the molecular signature unique to MBTPS2 -OI to infer the pathogenicity of a novel MBTPS2 c.516A>C (p.Glu172Asp) variant of unknown significance in a male proband. The pregnancy was terminated at gestational week 21 after ultrasound scans showed bowing of femurs and tibiae and shortening of long bones particularly of the lower extremity; these were further confirmed by autopsy. By performing transcriptional analyses, gas chromatography-tandem mass spectrometry-based quantification of fatty acids and immunocytochemistry on fibroblasts derived from the umbilical cord of the proband, we observed perturbations in fatty acid metabolism and collagen production similar to what we previously described in MBTPS2 -OI. These findings support pathogenicity of the MBTPS2 variant p.Glu172Asp as OI-causative and highlights the value of extrapolating molecular signatures identified in multiomics studies to characterize novel genetic variants.

Idiopathic juvenile osteoporosis-a polygenic disorder?

The idiopathic juvenile osteoporosis

Idiopathic Juvenile Osteoporosis: A Case Report and Literature Review

Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties

NOVEL MUTATIONS IN THE WNT1, TMEM38B, P4HB, AND PLS3 GENES IN FOUR UNRELATED CHINESE FAMILIES WITH OSTEOGENESIS IMPERFECTA.

Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene

High bone mass phenotype in a cohort of patients with Osteogenesis Imperfecta caused due to BMP1 and C-propeptide cleavage variants in COL1A1

Early‐onset osteoporosis: Rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen

Novel mutations in BMP1 result in a patient with autosomal recessive osteogenesis imperfecta

Genetic Anomalies in Pediatric Orthopedics: A Case Study of a New Rare Sporadic Mutation of Osteogenesis Imperfecta

A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis

Management of Osteogenesis Imperfecta

Genotype-Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease.

Osteogenesis imperfecta: shifting paradigms in pathophysiology and care in children

LRP5 Variant Without Pseudoglioma in a Young Man With Fragility Fractures

Current concepts in osteogenesis imperfecta: Bone structure, biomechanics and medical management

Genotypic And Phenotypic Characteristics Of 29 Patients With Rare Types Of Osteogenesis Imperfecta: Average 5 Years Of Follow-Up

Application of Next-Generation Sequencing for Molecular Diagnosis in a Large Family with Osteogenesis Imperfecta Type I

Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study

Current Overview of Osteogenesis Imperfecta

Perturbations in fatty acid metabolism and collagen production infer pathogenicity of a novel MBTPS2 variant in Osteogenesis imperfecta